TD ASSET MANAGEMENT INC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$208,000
+51.8%
20,418
+100.0%
0.00%
Q3 2021$137,000
-22.6%
10,2090.0%0.00%
Q2 2021$177,000
-75.6%
10,209
-66.1%
0.00%
-100.0%
Q1 2021$724,000
+39.5%
30,081
+4.3%
0.00%0.0%
Q4 2020$519,000
+55.9%
28,8420.0%0.00%
Q3 2020$333,000
-52.4%
28,8420.0%0.00%
-100.0%
Q2 2020$700,000
+135.7%
28,842
+7.1%
0.00%0.0%
Q1 2020$297,000
-68.6%
26,942
-24.6%
0.00%0.0%
Q4 2019$945,000
+0.3%
35,742
-13.5%
0.00%0.0%
Q3 2019$942,000
-6.7%
41,342
+25.5%
0.00%
-50.0%
Q2 2019$1,010,000
+41.9%
32,950
-23.2%
0.00%
+100.0%
Q1 2019$712,000
-12.5%
42,891
+0.9%
0.00%0.0%
Q4 2018$814,000
-66.7%
42,491
-9.1%
0.00%
-75.0%
Q3 2018$2,444,000
+72.1%
46,743
+43.1%
0.00%
+100.0%
Q2 2018$1,420,000
+48.4%
32,668
+26.4%
0.00%
+100.0%
Q1 2018$957,00025,8360.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 856,798$6,512,0001.75%
CHI Advisors LLC 488,635$3,714,0001.58%
Pinz Capital Management, LP 186,515$1,418,0000.88%
Lombard Odier Asset Management (Switzerland) SA 542,183$4,121,0000.32%
Rhenman & Partners Asset Management AB 316,137$2,403,0000.24%
Birchview Capital, LP 40,000$304,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 160,000$1,216,0000.18%
Tekla Capital Management LLC 423,869$3,221,0000.11%
Golden Green, Inc. 12,152$92,0000.08%
Virtus ETF Advisers LLC 15,188$115,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders